Trials / Conditions / Hematologic Cancers
Hematologic Cancers
4 registered clinical trials studyying Hematologic Cancers — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Study of SRF231 in Patients With Advanced Solid and Hematologic Cancers NCT03512340 | Surface Oncology | Phase 1 |
| Active Not Recruiting | Phase 2 Study Assessing Secured Access to Vemurafenib for Patients With Tumors Harboring BRAF Genomic Alterati NCT02304809 | UNICANCER | Phase 2 |
| Completed | Phase 2 Study Assessing Efficacy and Safety of Crizotinib in Patients Harboring an Alteration on ALK, MET or R NCT02034981 | UNICANCER | Phase 2 |
| Recruiting | Genomic Profiling in Cancer Patients NCT01775072 | Memorial Sloan Kettering Cancer Center | — |